Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Adenosine to facilitate the clipping of cerebral aneurysms: literature review.
Desai VR, Rosas AL, Britz GW.
Stroke Vasc Neurol. 2017 Jun 23;2(4):204-209. doi: 10.1136/svn-2017-000082. eCollection 2017 Dec. Review.
Similar articles
Giant symptomatic capillary telangiectasia of the brain.
Andrade CS, Gattás GS, Rosas AL, Leite Cda C.
Arq Neuropsiquiatr. 2015 Jan;73(1):66-7. doi: 10.1590/0004-282X20140185. Epub 2015 Jan 1. No abstract available.
Combined hematopoietic and lentiviral gene-transfer therapies in newborn Twitcher mice reveal contemporaneous neurodegeneration and demyelination in Krabbe disease.
Galbiati F, Givogri MI, Cantuti L, Rosas AL, Cao H, van Breemen R, Bongarzone ER.
J Neurosci Res. 2009 Jun;87(8):1748-59. doi: 10.1002/jnr.22006.
The many guises of pheochromocytoma: insights from a case report.
Rosas AL.
South Med J. 2008 Apr;101(4):354-5. doi: 10.1097/SMJ.0b013e318167acd4. No abstract available.
Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature.
Rosas AL, Kasperlik-Zaluska AA, Papierska L, Bass BL, Pacak K, Eisenhofer G.
Eur J Endocrinol. 2008 Mar;158(3):423-9. doi: 10.1530/EJE-07-0778. Review.
Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.
Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM, Pacak K.
Drug Saf. 2007;30(11):1031-62. Review.
Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling.
Wang JY, Chang AH, Guttormsen HK, Rosas AL, Kasper DL.
Vaccine. 2003 Mar 7;21(11-12):1112-7.
Activation of the alternative complement pathway by fungal melanins.
Rosas AL, MacGill RS, Nosanchuk JD, Kozel TR, Casadevall A.
Clin Diagn Lab Immunol. 2002 Jan;9(1):144-8.
Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation.
Rosas AL, Casadevall A.
Mycopathologia. 2001;151(2):53-6.
Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection.
Rosas AL, Nosanchuk JD, Casadevall A.
Infect Immun. 2001 May;69(5):3410-2.
Isolation and serological analyses of fungal melanins.
Rosas AL, Nosanchuk JD, Gómez BL, Edens WA, Henson JM, Casadevall A.
J Immunol Methods. 2000 Oct 20;244(1-2):69-80.
Melanin and virulence in Cryptococcus neoformans.
Casadevall A, Rosas AL, Nosanchuk JD.
Curr Opin Microbiol. 2000 Aug;3(4):354-8. Review.
Melanisation of Cryptococcus neoformans in human brain tissue.
Nosanchuk JD, Rosas AL, Lee SC, Casadevall A.
Lancet. 2000 Jun 10;355(9220):2049-50.
Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents.
Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A.
Infect Immun. 2000 May;68(5):2845-53.
Evidence that Cryptococcus neoformans is melanized in pigeon excreta: implications for pathogenesis.
Nosanchuk JD, Rudolph J, Rosas AL, Casadevall A.
Infect Immun. 1999 Oct;67(10):5477-9.
Bilateral anterior ischemic optic neuropathy and branch retinal artery occlusion after radical prostatectomy.
Williams GC, Lee AG, Adler HL, Coburn A, Rosas AL, Tang RA, Scardino PT.
J Urol. 1999 Oct;162(4):1384-5. No abstract available.
The antibody response to fungal melanin in mice.
Nosanchuk JD, Rosas AL, Casadevall A.
J Immunol. 1998 Jun 15;160(12):6026-31.
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.
Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski LA, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z.
Antimicrob Agents Chemother. 1998 Jun;42(6):1437-46.
Melanization affects susceptibility of Cryptococcus neoformans to heat and cold.
FEMS Microbiol Lett. 1997 Aug 15;153(2):265-72. Erratum in: FEMS Microbiol Lett 1997 Nov 1;156(1):171.
Risk factors for complications and morbidity after radical retropubic prostatectomy.
Dillioglugil O, Leibman BD, Leibman NS, Kattan MW, Rosas AL, Scardino PT.
J Urol. 1997 May;157(5):1760-7. Review.
Filters: Manage Filters